ZFIN ID: ZDB-FIG-171204-3
Nishimura et al., 2015 - Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity. Frontiers in pharmacology   6:199 Full text @ Front Pharmacol
Observed In:
Stage: Adult

Fig. S1 ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Gene Expression Details No data available
Antibody Labeling Details No data available
Phenotype Details
Fish Conditions Stage Phenotype
mitfab692/b692 ; ednrbab140/b140 increased food availability Adult blood plasma triglyceride increased amount, abnormal
Adult visceral fat increased amount, abnormal
Adult whole organism increased weight, abnormal
mitfab692/b692 ; ednrbab140/b140 chemical treatment by diet: resveratrol, increased food availability Adult blood plasma triglyceride amount, ameliorated
Adult visceral fat amount, ameliorated
Adult whole organism weight, ameliorated
ZFIN wishes to thank the journal Frontiers in pharmacology for permission to reproduce figures from this article. Please note that this material may be protected by copyright. Full text @ Front Pharmacol